The DOI matches its Crossref record, with a small difference in title or year; 23 of the 23 references it cites were found in a registry or an index.
RETINAL ANGIOMATOUS PROLIFERATION: Natural History and Progression of Visual Loss
Abstract
PURPOSE: To investigate the natural history and visual outcome in eyes with untreated retinal angiomatous proliferation, a neovascular form of age-related macular degeneration. METHODS: Fourteen consecutive white patients (11 women, 78%; mean age, 74 years) with 16 eyes affected by retinal angiomatous proliferation were prospectively followed-up without treatment by means of complete ophthalmologic examinations at regular intervals, including best-corrected visual acuity and dynamic fluorescein and indocyanine green angiography using a scanning laser ophthalmoscope. RESULTS: The patients were observed for a mean of 20 months (range, 6-44 months). Mean visual acuity in the eyes with retinal angiomatous proliferation was 0.48 at the initial examination, decreased to 0.23 after 6 months, and was 0.19 at the final examination, with a mean decrease of 6 lines from baseline. In 13 eyes (81%), visual acuity deteriorated by 2 Early Treatment Diabetic Retinopathy Study lines or worse by the time of the 6-month examination, and 31% of the patients had experienced severe loss of vision; the remaining 3 eyes (19%) showed a relatively stable clinical course and visual acuity. By the time of the final examination, visual acuity had decreased to 0.1 or worse in 11 eyes (69%), and 5 of the 14 patients (36%) were legally blind. At the final examination, 10 eyes (62%) showed a subretinal fibrosis and 9 (56%) showed a retinal choroidal anastomosis. CONCLUSION: Retinal angiomatous proliferation is a distinct form of neovascular age-related macular degeneration with high vasogenic potential, having its own clinical course and visual prognosis. The poor visual outcome is because of the exudative nature of the retinal angiomatous proliferation, and progression to poor vision is common and rapid (within 3 months in faster cases, and within 1 year in slower cases). The treatment options for this type of neovascular lesion should be planned bearing in mind its unfavorable natural history.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A relatively small study that followed the natural history of RAP lesions for a mean duration of 20 months found subretinal fibrosis on FA and red-free photographs in 10 of 16 eyes (62%),38”
From Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials (2014) · cites this paper as [38]
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Fung, A. E., Lalwani, G. A., Rosenfeld, P. J., Dubovy, S. R., Michels, S., Feuer, W. J., Puliafito, C. A., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.028 · Cited by 972
(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00967-9 · Cited by 814
Bressler, N. M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01237-5 · Cited by 666
RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION
Yannuzzi, L. A., Negrão, S., IIDA, T., Carvalho, C., Rodriguez-Coleman, H., Slakter, J., Freund, K. B., Sorenson, J., Orlock, D., & Borodoker, N. (2012) · Retina · doi:10.1097/iae.0b013e31823f9b3b · Cited by 660
RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION
YANNUZZI, L. A., NEGRÃO, S., IIDA, T., CARVALHO, C., RODRIGUEZ-COLEMAN, H., SLAKTER, J., FREUND, K. B., SORENSON, J., ORLOCK, D., & BORODOKER, N. (2001) · Retina · doi:10.1097/00006982-200110000-00003 · Cited by 659
The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
Wong, T., Chakravarthy, U., Klein, R., Mitchell, P., Zlateva, G., Buggage, R., Fahrbach, K., Probst, C., & Sledge, I. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.008 · Cited by 601
TYPE 3 NEOVASCULARIZATION: The Expanded Spectrum of Retinal Angiomatous Proliferation
FREUND, K. B., -VAN HO, I., BARBAZETTO, I. A., KOIZUMI, H., LAUD, K., FERRARA, D., MATSUMOTO, Y., SORENSON, J. A., & YANNUZZI, L. (2008) · Retina · doi:10.1097/iae.0b013e3181669504 · Cited by 295
Deep Retinal Vascular Anomalous Complexes in Advanced Age-related Macular Degeneration
Hartnett, M. E., Weiter, J. J., Staurenghi, G., & Elsner, A. E. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30389-8 · Cited by 216
Self-citationGASS, J. D. M., AGARWAL, A., LAVINA, A. M., & TAWANSY, K. A. (2003) · RETINA · doi:10.1097/00006982-200312000-00001 · Cited by 174
Imaging of Chorioretinal Anastomoses in Vascularized Retinal Pigment Epithelium Detachments
Kuhn, D. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100110052025 · Cited by 171
Slakter, J. S., Yannuzzi, L. A., Schneider, U., Sorenson, J. A., Ciardella, A., Guyer, D. R., Spaide, R. F., Freund, K. B., & Orlock, D. A. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00009-9 · Cited by 171
Review of Retinal Angiomatous Proliferation or Type 3 Neovascularization
Yannuzzi, L. A., Freund, K. B., & Takahashi, B. S. (2008) · Retina · doi:10.1097/iae.0b013e3181619c55 · Cited by 157
GROSS, N. E., Aizman, A., BRUCKER, A. J., Klancnik, J. M., & Yannuzzi, L. A. (2005) · Retina · doi:10.1097/00006982-200509000-00005 · Cited by 150
Treatment of Retinal Angiomatous Proliferation in Age-Related Macular Degeneration
Bottoni, F. G. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.12.1644 · Cited by 128
Lafaut, B. A. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.11.1269 · Cited by 99
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR RETINAL ANGIOMATOUS PROLIFERATION
MEYERLE, C. B., Freund, K. B., Iturralde, D., Spaide, R. F., Sorenson, J. A., Slakter, J. S., Klancnik, J. M., Fisher, Y. L., Cooney, M. J., & Yannuzzi, L. A. (2007) · Retina · doi:10.1097/iae.0b013e318030ea80 · Cited by 88
Freund, K. B. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.4.487 · Cited by 69
High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation
TRUONG, S. N., Alam, S., Zawadzki, R. J., et al. (2007) · eScholarship (California Digital Library) · Cited by 55
HIGH RESOLUTION FOURIER-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OF RETINAL ANGIOMATOUS PROLIFERATION
TRUONG, S. N., Alam, S., Zawadzki, R. J., CHOI, S. S., Telander, D. G., Park, S. S., Werner, J. S., & Morse, L. S. (2007) · Retina · doi:10.1097/iae.0b013e31805468fd · Cited by 55
Retinal Anastomosis to Choroidal Neovascularization
Bressler, N. M. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.12.1741 · Cited by 33
Massacesi, A., Sacchi, L., Bergamini, F., & Bottoni, F. G. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0638-x · Cited by 30
Self-citation
Cited by
Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
Daniel, E., Toth, C. A., Grunwald, J. E., Jaffe, G. J., Martin, D. F., Fine, S. L., Huang, J., Ying, G.-S., Hagstrom, S. A., Winter, K., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.019 · Cited by 335
Little, K., Llorián‐Salvador, M., Tang, M., Du, X., Marry, S., Chen, M., & Xu, H. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02033-7 · Cited by 157
Wang, J., Jiang, J., Zhang, Y.-Y., Qian, Y., Zhang, J., & Wang, Z. L. (2019) · Biomedical Optics Express · doi:10.1364/boe.10.001532 · Cited by 159
Joussen, A. M., Ryan, S. J., Kirchhof, B., & Gardner, T. W. (2007) · Springer eBooks · doi:10.1007/978-3-540-29542-6 · Cited by 130
Little, K., Jacey, H., Yang, N., Chen, M., & Xu, H. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.029 · Cited by 131
Metadata
- Authors
- VIOLA, F., MASSACESI, A., ORZALESI, N., RATIGLIA, R., & STAURENGHI, G.
- Affiliations
- University of Milan (IT)
- Ospedale San Giuseppe (IT)
- Corresponding author
- VIOLA, FRANCESCO
- RATIGLIA, ROBERTO
- Venue
- Retina
- Published
- 2009-06
- Volume
- 29
- Issue
- 6
- Pages
- 732-739
- ISSN
- 0275-004X (ISSN-L)
- OpenAlex
- W1990850867
- Cited by
- 79
- References
- 22
- Citations by year
- 2025: 3 · 2024: 6 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 7 · 2012: 7
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Retina (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- retinal angiomatous proliferation, neovascular age-related macular degeneration, natural history (disease), visual acuity loss, visual prognosis, subretinal fibrosis
- MeSH terms
- Aged, Aged, 80 and over, Arteriovenous Anastomosis, Blindness, Choroid, Coloring Agents, Female, Fibrosis, Fluorescein Angiography, Humans, Indocyanine Green, Macular Degeneration, Male, Middle Aged, Ophthalmoscopy, Retina, Retinal Vessels, Visual Acuity, Retinal Neovascularization, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.